The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index; 32 of the 47 sources its claims cite were checked for support.
Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology
Open accessAbstract
Imaging technologies are being increasingly used in biomedical research and experimental toxicology to gather morphological and functional information from cellular models. There is a concrete opportunity of incorporating imaging-based in vitro methods in international guidelines to respond to regulatory requirements with human relevant data. To translate these methods from R&D to international regulatory acceptance, the community needs to implement test methods under quality management systems, assess inter-laboratory transferability, and demonstrate data reliability and robustness. This article summarises current challenges associated with image acquisition, image analysis, including artificial intelligence, and data management of imaging-based methods, with examples from the developmental neurotoxicity in vitro battery and phenotypic profiling assays. The article includes considerations on specific needs and potential solutions to design and implement future validation and transferability studies.
Overview
CoChat Summary
TL;DR
This review/perspective summarizes challenges and recommendations for translating imaging-based in vitro methods from biomedical research to regulatory toxicology, focusing on image acquisition, analysis/AI, metadata, data management, transferability, reproducibility, and quality assurance. It uses the developmental neurotoxicity in vitro battery and phenotypic profiling/Cell Painting as examples and argues that standardisation, validation, and transparent reporting are needed for OECD test guideline acceptance.
Key findings
- Imaging-based in vitro methods generate digital images that require processing and analysis; regulatory acceptance requires implementation under quality management systems, assessment of inter-laboratory transferability, and demonstration of data reliability and robustness.
- The developmental neurotoxicity in vitro battery (DNT IVB) was supported by EFSA, which funded assessment of 120 substances; OECD proposed approximately 100 chemicals as DNT reference chemicals, and performance analysis confirmed high reproducibility and accuracy while identifying needs for glia-specific toxicity methods and exclusively human-based cell systems.
- Cell Painting/phenotypic profiling has been tested on over 1000 chemicals, with profiles available in the EPA CompTox Chemicals Dashboard; in vitro points-of-departure from human cells were similar or more conservative than in vivo animal points-of-departure for 68% of chemicals tested.
- Recommendations include systematic instrument calibration, standardised open formats (e.g., OME.tiff, OME-Zarr, DICOM), comprehensive metadata and ontologies, data management plans, GLP-compatible archiving (up to 15 years in some jurisdictions), and transparent AI validation; a sensitivity/specificity balance of around 80% for both is usually accepted for regulatory decision-making.
Methods
- Narrative review/perspective; no primary experimental data are reported. It synthesizes current challenges and platform-agnostic recommendations across the imaging workflow, with examples from the DNT IVB and phenotypic profiling/Cell Painting.
- Draws on cited literature, OECD guidance documents (e.g., GD34, GIVIMP), FDA/ICH/IVDR frameworks, and community initiatives (e.g., QUAREP-LiMi, Euro-BioImaging, Bigpicture); no sample, dataset, or statistical analysis is described.
Limitations
- The paper states that considerations on the choice of the best biological model and downstream data analysis of parameters extracted from images are out of scope; the focus is on technology and the imaging workflow.
- The paper states that existing GLP principles may not be fully applicable to emerging technologies, that capturing comprehensive metadata remains a challenge, that commercial software’s proprietary algorithms limit transparency, and that systematic instrument calibration is often overlooked.
- Evident from the text: as a review/perspective, the recommendations are not empirically validated in a single study, and no formal limitations section or primary data are presented; regulatory acceptance pathways for imaging-based in vitro methods remain aspirational.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
21 Valid · 1 Not valid · 10 Not checked · 32 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Recently, a DNT in vitro battery (DNT IVB) has been assembled (Sachana, Shafer, and Terron 2021; Harrill et al. 2018; Blum et al. 2023), comprising of multiple test methods assessing individual key neurodevelopmental processes (KNDPs).”
§ Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology > Introduction > Use of imaging technologies in medical regulated fields
What the sources say
- Supportedcites Sachana, Shafer, and Terron 2021 source
Section 3 says the DNT in vitro battery includes multiple assays designed around key neurodevelopmental processes. Section 3.1 states that each assay evaluates a key neurodevelopmental event, and the Conclusions state that multiple tests have been assembled into a battery. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites Harrill et al. 2018 source
- Not checked — no full text of the sourcecites Blum et al. 2023 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In vitro points-of-departures derived from human cells with CP were similar or more conservative than in vivo animal points-of-departure for 68% of the chemical tested (Nyffeler et al. 2020).”
§ Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology > Introduction > Use of imaging technologies in medical regulated fields
What the sources say
- Supportedcites Nyffeler et al. 2020 source
The Results report that Cell Painting-derived HTPP administered equivalent doses were conservative or comparable to in vivo points of departure for 68% (285/420) of chemicals with the data needed for comparison. The Introduction identifies the assay cells as human-derived; the 68% denominator is the 420 comparable chemicals, not all 462 screened. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Data generated using the DNT IVB has been used for hazard identification in EFSA-coordinated case studies on pesticides such as deltamethrin, acetamiprid, and flufenacet. (OECD 2023a; EFSA et al. 2024).”
§ Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology > Introduction > Use of imaging technologies in medical regulated fields
What the sources say
- Not matchedcites OECD 2023a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Supportedcites EFSA et al. 2024 source
The Recommendations > Human health section names EFSA’s three pesticide IATA case studies—deltamethrin, flufenacet and acetamiprid—and describes the framework as an approach to DNT hazard identification that integrates DNT IVB results. The Hazard assessment acetamiprid section also states that acetamiprid was tested in all DNT IVB assays. Page numbers were not available in our copy. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The current testing paradigm for DNT mainly relies on results on results from in vivo guideline studies (OECD TG 426 (OECD 2007), OECD TG 443 with DNT cohort (OECD 2018a)).”
§ Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology > Introduction > Use of imaging technologies in medical regulated fields
What the sources say
- Supportedcites OECD 2007 source
This citation identifies OECD TG 426 as an in vivo developmental neurotoxicity guideline study. Sections 2 and 3 describe its study of offspring exposed during development and require compliance with guidelines for laboratory animal research. The separate citation to OECD 2018a is attached to TG 443; this source is not being cited to identify that guideline. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites OECD 2018a source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Capturing comprehensive metadata throughout the experimental workflow remains a challenge, as highlighted in a recent survey (Schmidt et al. 2022).”
§ Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology > Imaging-based in vitro methods towards regulatory use
What the sources say
- Supportedcites Schmidt et al. 2022 source
In Results and discussion (page unavailable), the survey reports that many respondents collect no metadata beyond what instruments save automatically, and that tools and guidelines for annotation are lacking. The Conclusions describe integrating metadata practices into the research data life cycle as an ongoing challenge. Together, these support the claim about capturing comprehensive metadata across the workflow. (LLM, conf=0.89)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
7 more claims · 3 with their cited sources checked
Create a free account to see all 64 claims and every source verdict.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 40
Citations
Cites
ImageJ2: ImageJ for the next generation of scientific image data
Rueden, C. T., Schindelin, J., Hiner, M. C., DeZonia, B. E., Walter, A. E., Arena, E. T., & Eliceiri, K. W. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1934-z · Cited by 5,980 · cited 2×
“Open-source solutions based on software platforms such as Fiji/ImageJ (Rueden et al. 2017), CellProfiler (Stir-ling et al. 2021; Soliman 2015) and pipelining software KNIME (Berthold et al. 2008) offer complete transparency of their code and are well suited to create bespoke workflows for specific use cases, which can…”
The Principles of Humane Experimental Technique
(1960) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1960.tb73127.x · Cited by 4,912
CellProfiler 4: improvements in speed, utility and usability
Stirling, D. R., Swain-Bowden, M. J., Lucas, A. M., Carpenter, A. E., Cimini, B. A., & Goodman, A. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04344-9 · Cited by 2,070
KNIME: The Konstanz Information Miner
Berthold, M. R., Cebron, N., Dill, F., Gabriel, T. R., Kötter, T., Meinl, T., Ohl, P., Sieb, C., Thiel, K., & Wiswedel, B. (2008) · Studies in Classification, Data Analysis, and Knowledge Organization · doi:10.1007/978-3-540-78246-9_38 · Cited by 1,251 · cited 2×
“…on software platforms such as Fiji/ImageJ (Rueden et al. 2017), CellProfiler (Stir-ling et al. 2021; Soliman 2015) and pipelining software KNIME (Berthold et al. 2008) offer complete transparency of their code and are well suited to create bespoke workflows for specific use cases, which can…”
Deep learning for cellular image analysis
Moen, E., Bannon, D., Kudo, T., Graf, W., Covert, M., & Van Valen, D. (2019) · Nature Methods · doi:10.1038/s41592-019-0403-1 · Cited by 1,225 · cited 1×
“Recently DL, a specialised form of ML algorithms using Deep Neural Networks, is increasingly applied for microscopy image and data analysis (Moen et al. 2019; Seo et al. 2020).”
KNIME - the Konstanz information miner: version 2.0 and beyond
Berthold, M. R., Cebron, N., Dill, F., Gabriel, T. R., Kötter, T., Meinl, T., Ohl, P., Thiel, K., & Wiswedel, B. (2009) · ACM SIGKDD Explorations Newsletter · doi:10.1145/1656274.1656280 · Cited by 1,189
Bray, M.-A., Singh, S., Han, H., Davis, C. T., Borgeson, B., Hartland, C., Kost-Alimova, M., Gustafsdottir, S. M., Gibson, C. C., & Carpenter, A. E. (2016) · Nature Protocols · doi:10.1038/nprot.2016.105 · Cited by 1,090
Metadata matters: access to image data in the real world
Linkert, M., Rueden, C. T., Allan, C., Burel, J.-M., Moore, W., Patterson, A., Loranger, B., Moore, J., Neves, C., MacDonald, D., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201004104 · Cited by 1,018 · cited 1×
“Metadata should be embedded within the image file itself or provided in supplementary files alongside the published images (Linkert et al. 2010; Hammer et al. 2021).”
Self-citationEBImage—an R package for image processing with applications to cellular phenotypes
Pau, G., Fuchs, F., Sklyar, O., Boutros, M., & Huber, W. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq046 · Cited by 797 · cited 1×
“…et al. 2008) offer complete transparency of their code and are well suited to create bespoke workflows for specific use cases, which can become particularly powerful when combined with open-source data analysis based on R (Meyer et al. 2024; Pau et al. 2010) or Python (Rueden et al. 2022).”
Data-analysis strategies for image-based cell profiling
Caicedo, J. C., Cooper, S., Heigwer, F., Warchal, S., Qiu, P., Molnar, C., Vasilevich, A. S., Barry, J. D., Bansal, H. S., Kraus, O., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4397 · Cited by 739 · cited 1×
“For this purpose, the generated microscopy images are used to extract many different image features using Machine Learning (ML) approaches based on handcrafted features and more recently using DL (Caicedo et al. 2017; Chan-drasekaran et al. 2021).”
Research works printed but not linked: 2
- National Academies of Sciences, Engineering and Medicine (2023) Building confidence in new evidence streams for human health risk assessment: lessons learned from laboratory mammalian toxicity tests. The National Academies Press, Washington, DC
- OECD (2018a) Extended one-generation reproductive toxicity study (EOGRTS) (OECD TG 443). https://www.oecd-ilibrary.org/content/component/9789264304741-34-en
Cited by
Morphological profiling data resource enables prediction of chemical compound properties
Wolff, C., Neuenschwander, M., Beese, C. J., Sitani, D., Ramos, M. C., Srovnalová, A., Varela, M. J., Полищук, П. Г., Skopelitou, K., Škuta, C., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112445 · Cited by 24
Self-citationMehrtabar, S., Marey, A., Desai, A., Saad, A. M., Desai, V. S., Goñi, J., Pal, B., & Umair, M. (2025) · Journal of Imaging Informatics in Medicine · doi:10.1007/s10278-025-01656-7 · Cited by 17
“Additional barriers to data sharing include the following [72, 73]: • technical incompatibilities in data formats (e.g., non-standard DICOM tags) • lack of uniform data annotation protocols • institutional reluctance to share proprietary data or patient information • lack of incentives or credit…”
New approach methodologies for risk assessment of urinary occurring toxicants
Jobst, M., Guerreiro, I., Payros, D., Oswald, I. P., Fernandes, A. S., Warth, B., & Favero, G. D. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118649 · Cited by 7
Kearney, H., Mihaila, S. M., Moroni, L., & Mota, C. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202504719 · Cited by 7
Cell painting in HepaRG cells: an interlaboratory reproducibility study
Sherer, E. A., Chen, W., Aberasturi, D. T., Sagar, K., Li, Y., Sutake, Z., Xu, J., Harris, F. R., Harrill, J., & LaRocca, J. L. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf139 · Cited by 1
Metadata
- Authors
- Piergiovanni, M., Mennecozzi, M., Barale-Thomas, E., Danovi, D., Dunst, S., Egan, D., Fassi, A., Hartley, M., Kainz, P., Koch, K., Le Dévédec, S. E., Mangas, I., Miranda, E., Nyffeler, J., Pesenti, E., Ricci, F., Schmied, C., Schreiner, A., Stokar-Regenscheit, N., Swedlow, J. R., Uhlmann, V., Wieland, F. C., Wilson, A., & Whelan, M.
- Affiliations
- European Commission (BE)
- Joint Research Centre (IT)
- Janssen (Belgium) (BE)
- King's College London (GB)
- German Federal Institute for Risk Assessment (BfR) (DE)
- European Bioinformatics Institute (GB)
- Leibniz Institute of Environmental Medicine (DE)
- European Food Safety Authority (IT)
- Axxam (Italy) (IT)
- EU-OPENSCREEN (DE)
- Revvity (United States) (US)
- University of Dundee (GB)
- University of Zurich (CH)
- AstraZeneca (United Kingdom) (GB)
- Corresponding author
- Piergiovanni, Monica
- ORCID
- Venue
- Archives of Toxicology
- Published
- 2025-02-13
- Volume
- 99
- Issue
- 4
- Pages
- 1271-1285
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- PMC
- PMC11968550
- OpenAlex
- W4407428151
- Semantic Scholar
- 8e0fade170169383d034f5ce3afcd2d4a1985c50
- Cited by
- 9
- References
- 99
- Citations by year
- 2026: 4 · 2025: 5
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Archives of Toxicology (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, cc-by-nc-nd)
- Leiden Repository (Leiden University) (submittedVersion, cc-by-nc-nd)
- OpenAgrar (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Cell Image Analysis Techniques
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Keywords
- regulatory toxicology, test method validation, quality management systems, image analysis, artificial intelligence, data management, developmental neurotoxicity, regulatory acceptance
- MeSH terms
- Animals, Artificial Intelligence, Humans, Image Processing, Computer-Assisted, Toxicology, Reproducibility of Results, Toxicity Tests, Biomedical Research, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology. https://app.cochat.ai/papers/10.1007/s00204-024-03922-z
- The paper
- Piergiovanni, M., Mennecozzi, M., Barale-Thomas, E., Danovi, D., Dunst, S., Egan, D., Fassi, A., Hartley, M., Kainz, P., Koch, K., Le Dévédec, S. E., Mangas, I., Miranda, E., Nyffeler, J., Pesenti, E., Ricci, F., Schmied, C., Schreiner, A., Stokar-Regenscheit, N., . . . Whelan, M. (2025). Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology. Archives of Toxicology. https://doi.org/10.1007/s00204-024-03922-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.